ANNORA PHARMA PRIVATE LIMITED
Location
Telangana
Founded
2015-11-26
Website
Risk Signals
4 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations, Guided Missile Space Vehicle Parts and Auxiliary Equipment, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about ANNORA PHARMA PRIVATE LIMITED
Live alerts from global media, monitored by Business Radar
2023-08-16 (bloomberglaw.com)
UCB Wins Patent Order Blocking Copies of Briviact Epilepsy Drug
UCB SA won a decision blocking copies of Briviact until 2026, as a federal judge upheld the validity of a patent three generic-drug makers had conceded their proposed versions of the epilepsy treatment infringe.
Read more